Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.30 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442281 | 0.93 | SLC7A5 (0.30) | SLC7A5 | |
| Threonine SCHEMBL5073183 | 0.91 | SLC7A5 (0.38) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| Threonine SCHEMBL6856748 | 0.90 | SLC7A5 (0.36) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| SCHEMBL1675353 | 0.89 | SLC7A5 (0.33) | SLC7A5SLC1A3SLC1A2SLC1A1P2RY10 | |
| Serine SCHEMBL5698241 | 0.84 | SLC7A5 (0.33) | SLC7A5SLC1A3SLC1A2SLC1A1USP2 | |
| Leucine SCHEMBL15323191 | 0.84 | SLC7A5 (0.53) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| Threonine SCHEMBL6367180 | 0.81 | METAP2 (0.35) | SLC7A5 | |
| Threonine SCHEMBL2076958 | 0.79 | NOS3 (0.37) | SLC7A5SLC1A3SLC1A2SLC1A1P2RY10 | |
| SCHEMBL28679561 | 0.79 | NAAA (0.33) | SLC7A5 | |
| SCHEMBL599033 | 0.79 | SLC7A5 (0.41) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4340592-A | OLICOPEPTIDES FOR DIETARY PURPOSES | ADIBI SIAMAK A | 1982-07-20 | — | — | US | claimed |
| US-9458197-B2 | Elastin digest compositions and methods utilizing same | HUMAN MATRIX SCIENCES, LLC (US) | 2016-10-04 | — | — | US | disclosed |
| US-20150004184-A1 | ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME | NULASTIN, INC. | 2015-01-01 | — | — | US | disclosed |
| US-8828927-B2 | Elastin digest compositions and methods utilizing same | HUMAN MATRIX SCIENCES, LLC (US) | 2014-09-09 | — | — | US | disclosed |
| US-20130295122-A1 | ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME | NULASTIN, INC. | 2013-11-07 | — | — | US | disclosed |
| US-8461113-B2 | Elastin digest compositions and methods utilizing same | HUMAN MATRIX SCIENCES, LLC (US) | 2013-06-11 | — | — | US | disclosed |
| US-7666829-B2 | contains manganese chloride, manganese sulfate or manganese nitrate and ferric ammonium citrate or ferric chloride, for treating skin disorders; stimulating production of insoluble elastin, or deposition of collagen, fibroblasts; improve the appearance of scar; wrinkle resistance | HUMAN MATRIX SCIENCES, LLC (US) | 2010-02-23 | — | — | US | disclosed |
| US-20090281044-A1 | ELASTIN DIGEST COMPOSITIONS AND METHODS UTILIZING SAME | NULASTIN, INC. | 2009-11-12 | — | — | US | disclosed |